Ctrl/Cmd K

Loading stock analysis…

Explore

Stocks
Screener
IPOs
News

Tools

Backtest
Portfolio
Wealth
ITR

Learn

Guides
Methodology

Company

About
Contact
Disclosures
Privacy
Terms

© 2026 Anvest. All rights reserved.

Designed & Engineered in India·harsh@anvest.in

Disclaimer: Anvest provides financial analytics, screening simulations, and planning tools for informational and educational purposes only. Anvest is not a SEBI-registered investment advisor or broker. Nothing herein constitutes investment advice or an offer to buy/sell securities. Full details on methodology and limitations are documented under Disclosures and Terms.

Stocks›Healthcare

Procter & Gamble Health Limited

PGHL · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹5,670.50

+₹157.00 (+2.85%)(1D)

₹4,707.0052 Week Range₹6,975.00

Chart Score AI Profile Fundamentals Technicals Financials Shareholding Peers Filings

Anvest Score

77/100

Valuation

55/100

Quality

100/100

Growth

76/100

Health

97/100

Momentum

50/100

Valuation
55
Quality
100
Growth
76
Health
97
Momentum
50

Loading company profile…

Loading fundamentals…

Loading technical indicators…

Loading financial statement…

Loading shareholding…

Loading peer comparison…

Loading filings…

More Page Context

Research at a glance

Procter & Gamble Health Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹5,670.5

Market cap

₹9,413 Cr

P/E ratio

26.38

P/B ratio

17.94

Dividend yield

Not available

ROE

Not available

RSI 14

62.84

1Y return

Not available

Procter & Gamble Health Limited FAQs

3 topics

ExpandCollapse

Related paths

Peer links appear when comparable names are available.

Open screener Curated screens Backtest ideas

What does the Procter & Gamble Health Limited (PGHL) stock page cover?

Procter & Gamble Health Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for PGHL?

Procter & Gamble Health Limited is currently shown with a delayed price near ₹5,670.5, P/E 26.38.

Does the PGHL page provide investment advice?

No. The PGHL page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring

Related insights

VIYASH

Viyash Scientific Limited · Healthcare

STAR

Strides Pharma Science Limited · Healthcare

AARTIPHARM

Aarti Pharmalabs Limited · Healthcare

ROE vs ROCE

Compare return on equity and return on capital employed for Indian stock analysis. Learn how debt distorts shareholder ratios on Anvest.

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Procter & Gamble Health Limited operates in Drug Manufacturers - Specialty & Generic within the Healthcare sector. The company's core business involves the manufacture and sale of healthcare products, specifically vitamins, minerals, and supplements, which account for 100% of its turnover.

Drug Manufacturers - Specialty & GenericCEO/MD:Milind ThatteHQ:Mumbai, Maharashtra

Business at a Glance

No other business activities contribute to its revenue.

What Looks Strong

Financial highlights are being recalculated.

What to Watch

Financial highlights are being recalculated.

Reports a single operating segment in its results filings.
The company generates revenue by selling a range of health products, including vitamins, supplements, and other over-the-counter and prescription medicines.
It utilizes a distribution network to reach pharmacies, hospitals, and consumers across India, leveraging its parent company's brand recognition and marketing capabilities.